AI Article Synopsis
- - Medullary thyroid carcinoma is a rare tumor originating from parafollicular C-cells, linked to hereditary syndromes like FMTC and MEN 2, or it can occur randomly.
- - A case is reported involving a 50-year-old man diagnosed with the cancer after a neck mass was identified and examined through fine needle aspiration and histopathology.
- - Key markers for diagnosis and monitoring include carcinoembryonic antigen (CEA) and calcitonin, highlighting the importance of early detection and treatment for better survival rates.
Article Abstract
Medullary thyroid carcinoma is a rare neuroendocrine tumor derived from parafollicular C-cells. It can be inherited as part of syndromes, such as familial medullary thyroid cancer (FMTC) and multiple endocrine neoplasia type 2 (MEN 2), or it can arise sporadically. We herein report a unique case of medullary thyroid carcinoma in a 50-year-old male who presented with a neck mass. Fine needle aspiration cytology (FNAC) of the thyroid and histopathological examination revealed a diagnosis of medullary thyroid carcinoma. Both carcinoembryonic antigen (CEA) and calcitonin are the key serum markers utilized in the diagnosis and monitoring of medullary thyroid cancer (MTC). Thorough evaluation, prompt identification, and efficient treatment constitute the pivotal measures for ensuring favorable survival outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11331271 | PMC |
| http://dx.doi.org/10.7759/cureus.64969 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!